nach oben

Endocrine Pathology

Erschienen in:

01.03.2016

Non-Coding RNAs in Thyroid Cancer

verfasst von: Ranran Zhang, Heather Hardin, Jidong Chen, Zhenying Guo, Ricardo V. Lloyd

Erschienen in: Endocrine Pathology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Non-coding (nc)RNAs are divided into small ncRNAs and long ncRNAs (lncRNAs). MicroRNAs (miRNAs) are small ncRNAS which are around 22 nucleotides in length that mediate post-transcriptional gene silencing. LncRNAs are greater than 200 bp in length. Each ncRNA can have multiple targets and can be regulated by multiple genetic factors. Because ncRNAs are not translated into proteins, they can only be detected at the nucleic acid level by in situ hybridization, by RT-PCR, or by sequencing which makes their detection more challenging in the routine pathology laboratory. A great deal of new information has accumulated about miRNAs in thyroid tissues during the past decade. Some of these studies have shown that deregulation of miRNAs may be useful in diagnostic pathology. Information about the role of lncRNA in the development of thyroid tumors is in the early stages of development, but new information is accumulating rapidly. In this review, we will discuss the recent progress in our understanding of the relationship between ncRNAs and the development of thyroid cancers and the potential uses of ncRNAs in the diagnosis and prognosis of thyroid tumors.

Irminger-Finger I, Kargul J, Laurent GJ (2014) Non-coding RNAs: a novel level of genome complexity. Int J Biochem Cell Biol 54:286.CrossRefPubMed

Amaral PP, Dinger ME, Mercer TR, Mattick JS (2008) The eukaryotic genome as an RNA machine. Science (80-) 319:1787–1789.CrossRefPubMed

Venkatesh T, Suresh PS, Tsutsumi R (2015) Non-coding RNAs: functions and applications in endocrine-related cancer. Mol Cell Endocrinol 416:88–96.CrossRefPubMed

Mattick JS (2009) The genetic signatures of noncoding RNAs. PLoS Genet 5:e1000459.PubMedCentralCrossRefPubMed

Kun Á, Szilágyi A, Könnyű B, Boza G, Zachar I, Szathmáry E (2015) The dynamics of the RNA world: insights and challenges. Ann N Y Acad Sci 1341:75–95.CrossRefPubMed

Eddy SR (2001) Non-coding RNA genes and the modern RNA world. Nat Rev Genet 2:919–929.CrossRefPubMed

Prensner JR, Chinnaiyan AM (2011) The emergence of lncRNAs in cancer biology. Cancer Discov 1:391–407.PubMedCentralCrossRefPubMed

Almeida MI, Reis RM, Calin GA (2011) MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res 717:1–8.CrossRefPubMed

Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS (2010) Non-coding RNAs: regulators of disease. J Pathol 220:126–139.CrossRefPubMed

10.

Mercer TR, Dinger ME, Mattick JS (2009) Long non-coding RNAs: insights into functions. Nat Rev Genet 10:155–159.CrossRefPubMed

11.

Urbanek MO, Nawrocka AU, Krzyzosiak WJ (2015) Small RNA detection by in situ hybridization methods. Int J Mol Sci 16:13259–13286.PubMedCentralCrossRefPubMed

12.

Vester B, Wengel J (2004) LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. Biochemistry 43:13233–13241.CrossRefPubMed

13.

Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A, Wu X, Vo HT, Ma XJ, Luo Y (2012) RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn 14:22–29.PubMedCentralCrossRefPubMed

14.

Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L, Vergara IA, Davicioni E, Erho N, Ghadessi M, Jenkins RB, Triche TJ, Malik R, Bedenis R, McGregor N, Ma T, Chen W, Han S, Jing X, Cao X, Wang X, Chandler B, Yan W, Siddiqui J, Kunju LP, Dhanasekaran SM, Pienta KJ, Feng FY, Chinnaiyan AM (2013) The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet 45:1392–1398.PubMedCentralCrossRefPubMed

15.

Guo Z, Hardin H, Montemayor-Garcia C, Asioli S, Righi A, Maletta F, Sapino A, Lloyd R V (2015) In situ hybridization analysis of miR-146b-5p and miR-21 in thyroid nodules: diagnostic implications. Endocr Pathol 26:157–163.CrossRefPubMed

16.

Huang W, Eickhoff JC, Mehraein-Ghomi F, Church DR, Wilding G, Basu HS (2015) Expression of spermidine/spermine N1-acetyl transferase (SSAT) in human prostate tissues is related to prostate cancer progression and metastasis. Prostate 75:1150–1159.CrossRefPubMed

17.

Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D, Musolino C (2012) Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer. Int J Oncol 41:1897–1912.PubMed

18.

Regazzi R, Guay C, Regazzi R (2013) Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol 9:513–52186.CrossRefPubMed

19.

Alix - Panabì eres C, Schwarzenbach H, Pantel K (2012) Circulating tumor cells and circulating tumor DNA. Annu Rev Med 63:199–215CrossRef

20.

Lebofsky R, Decraene C, Bernard V, Kamal M, Blin A, Leroy Q, Frio TR, Pierron EG, Eline Callens C, Bieche I, Saliou A, Madic J, Rouleau E, Ement Bidard F-C, Lantz O, Stern M-H, Le Tourneau C, Pierga J-Y (2015) Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types. Mol Oncol 9:783–790.CrossRefPubMed

21.

Nikiforov YE, Nikiforova MN (2011) Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol 7:569–580.CrossRefPubMed

22.

Livolsi VA (2011) Papillary thyroid carcinoma: an update. Mod Pathol 24:S1–9.CrossRefPubMed

23.

Salvatore G, Pallante P, Battista S, Pierantoni GM, Fusco A, Pallante P, Battista S, Pierantoni GM, Fusco A (2013) Deregulation of microRNA expression in thyroid neoplasias. Nat Rev Endocrinol. doi: 10.1038/nrendo.2013.223 PubMedCentralPubMed

24.

Lin S, Gregory RI (2015) MicroRNA biogenesis pathways in cancer. Nat Rev Cancer 15:321–333.CrossRefPubMed

25.

Jonas S, Izaurralde E (2015) Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet 16:421–433.CrossRefPubMed

26.

Pennelli G, Galuppini F, Barollo SB, Cavedon E, Bertazza L, Fassan M, Guzzardo VB, Rosa Pelizzo M, Rugge M, Mian C (2015) The PDCD4/miR-21 pathway in medullary thyroid carcinoma. Hum Pathol 46:50–57.CrossRefPubMed

27.

Zhang J, Yang Y, Liu Y, Fan Y, Liu Z, Wang X, Yuan Q, Yin Y, Yu J, Zhu M, Zheng J, Lu X (2014) MicroRNA-21 regulates biological behaviors in papillary thyroid carcinoma by targeting programmed cell death 4. J Surg Res 189:68–74.CrossRefPubMed

28.

Fuziwara CS, Kimura ET (2014) MicroRNA deregulation in anaplastic thyroid cancer biology. Int J Endocrinol 2014:743450.PubMedCentralCrossRefPubMed

29.

Mancikova V, Castelblanco E, Pineiro-Yanez E, Perales-Paton J, De Cubas AA, Inglada-Perez L, Matias-Guiu X, Capel I, Bella M, Lerma E, Riesco-Eizaguirre G, Santisteban P, Maravall F, Mauricio D, Al-Shahrour F, Robledo M (2015) MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumors. Mod Pathol 28:748–757.CrossRefPubMed

30.

Chruścik A, Lam AK (2015) Clinical pathological impacts of microRNAs in papillary thyroid carcinoma: a crucial review. Exp Mol Pathol 99:393–398.CrossRefPubMed

31.

Sun Y, Yu S, Liu Y, Wang F, Liu Y, Xiao H (2013) Clinical study expression of miRNAs in papillary thyroid carcinomas is associated with BRAF mutation and clinicopathological features in Chinese patients. Int J Endocrinol. doi: 10.1155/2013/128735

32.

Visone R, Russo L, Pallante P, De Martino I, Ferraro A, Leone V, Borbone E, Petrocca F, Alder H, Croce CM, Fusco A (2007) MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27 Kip1 protein levels and cell cycle. Endocr Relat Cancer 14:791–798.CrossRefPubMed

33.

Pacifico F, Crescenzi E, Mellone S, Iannetti A, Porrino N, Liguoro D, Moscato F, Grieco M, Formisano S, Leonardi A (2010) Nuclear factor-kB contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a. J Clin Endocrinol Metab 95:1421–1430.CrossRefPubMed

34.

Zhang Z, Liu Z-B, Ren W-M, Ye X-G, Zhang Y-Y (2012) The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells. Int J Mol Med 30:856–862.PubMed

35.

Dettmer MS, Perren A, Moch H, Komminoth P, Nikiforov YE, Nikiforova MN (2014) MicroRNA profile of poorly differentiated thyroid carcinomas—new diagnostic and prognostic insights. J Mol Endocrinol 52:181–189.PubMedCentralCrossRefPubMed

36.

Hudson J, Duncavage E, Tamburrino A, Salerno P, Xi L, Raffeld M, Moley J, Chernock RD (2013) Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma. Exp Mol Pathol 95:62–67.PubMedCentralCrossRefPubMed

37.

Gundara JS, Ting Zhao J, Gill AJ, Clifton-Bligh R, Robinson BG, Delbridge L, Sidhu SB, Professor Stan Sidhu CB, Gundara MBBS JS, Zhao JT, Gill AJ, Clifton-Bligh R, Robinson BG, Delbridge L, Sidhu SB (2012) Nodal metastasis microRNA expression correlates with the primary tumour in MTC. ANZ J Surg 84:235–239.CrossRefPubMed

38.

Santarpia L, Calin GA, Adam L, Ye L, Fusco A, Giunti S, Thaller C, Paladini L, Zhang X, Jimenez C, Trimarchi F, El-Naggar AK, Gagel RF (2013) A miRNA signature associated with human metastatic medullary thyroid carcinoma. Endocr Relat Cancer 20:809–823.CrossRefPubMed

39.

Duan L, Hao X, Liu Z, Zhang Y, Zhang G (2014) MiR-129-5p is down-regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET. FEBS Lett 588:1644–1651.CrossRefPubMed

40.

Faam B, Ghaffari MA, Ghadiri A, Azizi F (2015) Epigenetic modifications in human thyroid cancer. Biomed Rep 3:3–8.PubMedCentralPubMed

41.

Hé Brant A, Bastien Floor S, Saiselet M, Antoniou A, Desbuleux A, Rengè Re Snyers B, La C, De Saint Aubain N, Leteurtre E, Andry G, Maenhaut C, Luque RM (2014) miRNA expression in anaplastic thyroid carcinomas. PLoS One 9:e103871.CrossRef

42.

Huang H, Luo X, Wu S, Jian B (2015) MiR-99a inhibits cell proliferation and tumorigenesis through targeting mTOR in human anaplastic thyroid cancer. Asian Pac J Cancer Prev 16:4937–4944.CrossRefPubMed

43.

Li X, Abdel-Mageed A, Mondal D, Kandil E (2013) MicroRNA expression profiles in differentiated thyroid cancer, a review. Int J Clin Exp Med 6:74–80.PubMedCentralPubMed

44.

Kanehisa M, Goto S (2000) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 28:

45.

Sheedy F, O’Neill L (2008) Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis Suppl 3:iii50–55.

46.

Chang C-J, Chao C-H, Xia W, Yang J-Y, Xiong Y, Li C-W, Yu W-H, Rehman SK, Hsu JL, Lee H-H, Liu M, Chen C-T, Yu D, Hung M-C (2011) p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 13:317–323.PubMedCentralCrossRefPubMed

47.

Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, Iwamoto K, Kume M, Kameoka Y, Takahashi N, Nakagawa T, Shimizu N, Sawada K (2011) The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 25:1324–1334.CrossRefPubMed

48.

Puppin C, Durante C, Sponziello M, Verrienti A, Pecce V, Lavarone E, Baldan F, Campese A, Boichard A, Lacroix L, Russo D, Filetti S, Damante G (2014) Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation. Endocrine 47:528–536.CrossRefPubMed

49.

Mattick JS, Rinn JL (2015) Discovery and annotation of long noncoding RNAs. Nat Struct Mol Biol 22:5–7.CrossRefPubMed

50.

Zhou Q, Chen J, Feng J, Wang J (2015) Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR). Tumour Biol. doi: 10.1007/s13277-015-4149-9

51.

Lan X, Zhang H, Wang Z, Dong W, Sun W, Shao L, Zhang T, Zhang D (2015) Genome-wide analysis of long noncoding RNA expression profile in papillary thyroid carcinoma. Gene 569:109–117.CrossRefPubMed

52.

Zheng H, Wang M, Jiang L, Chu H, Hu J, Ning J, Li B, Wang D, Xu J (2015) BRAF-activated long non-coding RNA modulates papillary thyroid carcinoma cell proliferation through regulating thyroid stimulating hormone receptor. Cancer Res Treat. doi: 10.4143/crt.2015.118 PubMed

53.

Wang Y, Guo Q, Zhao Y, Chen J, Wang S, Hu J, Sun Y (2014) BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma. Oncol Lett 8:1947–1952.PubMedCentralPubMed

54.

Lan X, Sun W, Zhang P, He L, Dong W, Wang Z, Liu S, Zhang H (2015) Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance. Tumour Biol. doi: 10.1007/s13277-015-4461-4

55.

He H, Nagy R, Liyanarachchi S, Jiao H, Li W, Suster S, Kere J, De La Chapelle A (2009) A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res 69:625–631.PubMedCentralCrossRefPubMed

56.

He H, Li W, Liyanarachchi S, Jendrzejewski J, Srinivas M, Davuluri R V, Nagy R, De La Chapelle A (2015) Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2. J Clin Endocrinol Metab 100:E164–172.PubMedCentralCrossRefPubMed

57.

Jendrzejewski J, Thomas A, Liyanarachchi S, Eiterman A, Tomsic J, He H, Radomska HS, Li W, Nagy R, Sworczak K, de la Chapelle A (2015) PTCSC3 is involved in papillary thyroid carcinoma development by modulating S100A4 gene expression. J Clin Endocrinol Metab 100:E1370–1377.CrossRefPubMed

58.

Fan M, Li X, Jiang W, Huang Y, Li J, Wang Z (2013) A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells. Exp Ther Med 5:1143–1146.PubMedCentralPubMed

59.

Gutschner T, Hämmerle M, Diederichs S (2013) MALAT1—a paradigm for long noncoding RNA function in cancer. J Mol Med 91:791–801.CrossRefPubMed

60.

Yoon JH, Kim E-K, Young J, Hee K, Moon J (2015) Effectiveness and limitations of core needle biopsy in the diagnosis of thyroid nodules: review of current literature. J Pathol Transl Med 49:230–235.PubMedCentralCrossRefPubMed

61.

Labourier E, Shifrin A, Busseniers AE, Lupo MA, Manganelli ML, Andruss B, Wylie D, Beaudenon-Huibregtse S (2015) Molecular testing for miRNA, mRNA, and DNA on fine-needle aspiration improves the preoperative diagnosis of thyroid nodules with indeterminate cytology. J Clin Endocrinol Metab 100:2743–2750.PubMedCentralCrossRefPubMed

62.

Diaz LA, Bardelli A (2014) Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol 32:579–586.CrossRefPubMed

63.

Lee JC, Ting Zhao J, Clifton-Bligh RJ, Gill A, Gundara JS, Ip JC, Glover A, Sywak MS, Delbridge LW, Robinson BG, Sidhu SB (2013) MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Cancer 119:4358–4365.CrossRefPubMed

Titel: Non-Coding RNAs in Thyroid Cancer
verfasst von: Ranran Zhang
Heather Hardin
Jidong Chen
Zhenying Guo
Ricardo V. Lloyd
Publikationsdatum: 01.03.2016
Verlag: Springer US
Erschienen in: Endocrine Pathology / Ausgabe 1/2016
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI: https://doi.org/10.1007/s12022-016-9417-8

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Non-Coding RNAs in Thyroid Cancer

Abstract

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2016

Parathyroid Lipoadenoma: a Clinicopathological Diagnosis and Possible Trap for the Unaware Pathologist

A Unique Case of Mediastinal Teratoma with Mature Pancreatic Tissue, Nesidioblastosis, and Aberrant Islet Differentiation: a Case Report and Literature Review

STK11 Mutation Identified in Thyroid Carcinoma

Hypoglycemic Syndrome without Hyperinsulinemia. A Diagnostic Challenge

Pigmented Pheochromocytoma: an Unusual Variant of a Common Tumor

Oncogene-Induced Senescence in Pituitary Adenomas—an Immunohistochemical Study

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie